231 related articles for article (PubMed ID: 31093971)
1. Identification of prognostic molecular biomarkers in 157 HPV-positive and HPV-negative squamous cell carcinomas of the oropharynx.
Dogan S; Xu B; Middha S; Vanderbilt CM; Bowman AS; Migliacci J; Morris LGT; Seshan VE; Ganly I
Int J Cancer; 2019 Dec; 145(11):3152-3162. PubMed ID: 31093971
[TBL] [Abstract][Full Text] [Related]
2. AKR1C3 is a biomarker and druggable target for oropharyngeal tumors.
Peraldo-Neia C; Ostano P; Mello-Grand M; Guana F; Gregnanin I; Boschi D; Oliaro-Bosso S; Pippione AC; Carenzo A; De Cecco L; Cavalieri S; Micali A; Perrone F; Averono G; Bagnasacco P; Dosdegani R; Masini L; Krengli M; Aluffi-Valletti P; Valente G; Chiorino G
Cell Oncol (Dordr); 2021 Apr; 44(2):357-372. PubMed ID: 33211282
[TBL] [Abstract][Full Text] [Related]
3. Mutation patterns in recurrent and/or metastatic oropharyngeal squamous cell carcinomas in relation to human papillomavirus status.
Reder H; Wagner S; Wuerdemann N; Langer C; Sandmann S; Braeuninger A; Dugas M; Gattenloehner S; Wittekindt C; Klussmann JP
Cancer Med; 2021 Feb; 10(4):1347-1356. PubMed ID: 33527763
[TBL] [Abstract][Full Text] [Related]
4. Stratification of HPV-associated and HPV-negative oropharyngeal squamous cell carcinomas based on DNA methylation epigenotypes.
Nakagawa T; Matsusaka K; Misawa K; Ota S; Fukuyo M; Rahmutulla B; Kunii N; Sakurai D; Hanazawa T; Matsubara H; Okamoto Y; Kaneda A
Int J Cancer; 2020 May; 146(9):2460-2474. PubMed ID: 31997344
[TBL] [Abstract][Full Text] [Related]
5. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
[TBL] [Abstract][Full Text] [Related]
6. HPV-positive oropharyngeal squamous cell carcinoma is associated with TIMP3 and CADM1 promoter hypermethylation.
van Kempen PM; van Bockel L; Braunius WW; Moelans CB; van Olst M; de Jong R; Stegeman I; van Diest PJ; Grolman W; Willems SM
Cancer Med; 2014 Oct; 3(5):1185-96. PubMed ID: 25065733
[TBL] [Abstract][Full Text] [Related]
7. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
[TBL] [Abstract][Full Text] [Related]
8. Investigation of somatic mutation profiles and tumor evolution of primary oropharyngeal cancer and sequential lymph node metastases using multiregional whole-exome sequencing.
Sim NS; Shin SJ; Park I; Yoon SO; Koh YW; Kim SH; Park YM
Mol Oncol; 2023 Jun; 17(6):981-992. PubMed ID: 36852664
[TBL] [Abstract][Full Text] [Related]
9. HPV+ oropharyngeal squamous cell carcinomas from patients with two tumors display synchrony of viral genomes yet discordant mutational profiles and signatures.
Faden DL; Langenbucher A; Kuhs K; Lewis JS; Mirabello L; Yeager M; Boland JF; Bass S; Steinberg M; Cullen M; Lawrence MS; Ferris RL
Carcinogenesis; 2021 Feb; 42(1):14-20. PubMed ID: 33075810
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations in human papillomavirus-associated oropharyngeal squamous cell carcinoma of patients with treatment failure.
Reder H; Wagner S; Gamerdinger U; Sandmann S; Wuerdemann N; Braeuninger A; Dugas M; Gattenloehner S; Klussmann JP; Wittekindt C
Oral Oncol; 2019 Jun; 93():59-65. PubMed ID: 31109697
[TBL] [Abstract][Full Text] [Related]
11. Analysis of Immunological Characteristics and Genomic Alterations in HPV-Positive Oropharyngeal Squamous Cell Carcinoma Based on PD-L1 Expression.
Xu SM; Shi CJ; Xia RH; Wang LZ; Tian Z; Ye WM; Liu L; Liu SL; Zhang CY; Hu YH; Zhou R; Han Y; Wang Y; Zhang ZY; Li J
Front Immunol; 2021; 12():798424. PubMed ID: 35145511
[TBL] [Abstract][Full Text] [Related]
12. Copy number gain of 11q13.3 genes associates with pathological stage in hypopharyngeal squamous cell carcinoma.
Pattle SB; Utjesanovic N; Togo A; Wells L; Conn B; Monaghan H; Junor E; Johannessen I; Cuschieri K; Talbot S
Genes Chromosomes Cancer; 2017 Mar; 56(3):185-198. PubMed ID: 27750372
[TBL] [Abstract][Full Text] [Related]
13. Elevated TLR5 expression in vivo and loss of NF-κΒ activation via TLR5 in vitro detected in HPV-negative oropharyngeal squamous cell carcinoma.
Kylmä AK; Tolvanen TA; Carpén T; Haglund C; Mäkitie A; Mattila PS; Grenman R; Jouhi L; Sorsa T; Lehtonen S; Hagström J
Exp Mol Pathol; 2020 Jun; 114():104435. PubMed ID: 32240617
[TBL] [Abstract][Full Text] [Related]
14. Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications.
Klussmann JP; Mooren JJ; Lehnen M; Claessen SM; Stenner M; Huebbers CU; Weissenborn SJ; Wedemeyer I; Preuss SF; Straetmans JM; Manni JJ; Hopman AH; Speel EJ
Clin Cancer Res; 2009 Mar; 15(5):1779-86. PubMed ID: 19223504
[TBL] [Abstract][Full Text] [Related]
15. Clinical relevance of copy number profiling in oral and oropharyngeal squamous cell carcinoma.
van Kempen PM; Noorlag R; Braunius WW; Moelans CB; Rifi W; Savola S; Koole R; Grolman W; van Es RJ; Willems SM
Cancer Med; 2015 Oct; 4(10):1525-35. PubMed ID: 26194878
[TBL] [Abstract][Full Text] [Related]
16. HPV Status Improves Classification of Head and Neck Gray Zone Cancers.
Ren J; Xu W; Su J; Ren X; Bender N; Habbous S; de Almeida JR; Goldstein DP; Cheng D; Chen Z; Mirshams M; Rahini M; Huang SH; Spreafico A; Hansen A; Kim J; Waldron J; Perez-Ordonez B; Zhao Y; Hung R; Waterboer T; Liu G
J Dent Res; 2019 Jul; 98(8):879-887. PubMed ID: 31282843
[TBL] [Abstract][Full Text] [Related]
17. A systematic investigation of the association between HPV and the clinicopathological parameters and prognosis of oral and oropharyngeal squamous cell carcinomas.
Wang F; Zhang H; Xue Y; Wen J; Zhou J; Yang X; Wei J
Cancer Med; 2017 May; 6(5):910-917. PubMed ID: 28378539
[TBL] [Abstract][Full Text] [Related]
18. Human Papillomavirus 16 Infection and TP53 Mutation: Two Distinct Pathogeneses for Oropharyngeal Squamous Cell Carcinoma in an Eastern Chinese Population.
Wang Z; Xia RH; Ye DX; Li J
PLoS One; 2016; 11(10):e0164491. PubMed ID: 27749915
[TBL] [Abstract][Full Text] [Related]
19. A functional variant at the miRNA binding site in E2F1 gene is associated with risk and tumor HPV16 status of oropharynx squamous cell carcinoma.
Yuan Y; Sturgis EM; Zhu L; Lu M; Li Y; Wei Q; Li G
Mol Carcinog; 2017 Mar; 56(3):1100-1106. PubMed ID: 27677255
[TBL] [Abstract][Full Text] [Related]
20. HPV circulating tumoral DNA quantification by droplet-based digital PCR: A promising predictive and prognostic biomarker for HPV-associated oropharyngeal cancers.
Veyer D; Wack M; Mandavit M; Garrigou S; Hans S; Bonfils P; Tartour E; Bélec L; Wang-Renault SF; Laurent-Puig P; Mirghani H; Rance B; Taly V; Badoual C; Péré H
Int J Cancer; 2020 Aug; 147(4):1222-1227. PubMed ID: 31756275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]